Is Wolff-Parkinson-White Syndrome Genetic?

Most cases of Wolff-Parkinson-White syndrome appear without any obvious family history, but the condition does have a genetic dimension. A large Swedish population study found that siblings of someone with WPW face roughly four times the usual risk of developing it themselves, even though familial cases account for less than one percent of all diagnoses. A handful of specific gene mutations can directly cause WPW as part of broader cardiac syndromes, yet for the majority of people who have the condition, no single gene has been pinpointed as the culprit.

How Common Is WPW and How Often Does It Run in Families

WPW affects roughly 1.5 to 3.1 out of every 1,000 people in Western populations, making it one of the more common causes of abnormally fast heart rhythms in otherwise healthy individuals.¹ The hallmark is an “accessory pathway,” an extra electrical connection between the upper and lower chambers of the heart that bypasses the normal conduction route. This shortcut can allow electrical signals to loop back on themselves, triggering episodes of rapid heartbeat.

Despite decades of case reports describing families where multiple members share the condition, truly familial WPW turns out to be uncommon. In a nationwide Swedish study that tracked over 3,100 people diagnosed with WPW and their siblings, only 14 cases, about 0.4 percent of the total, qualified as familial. Yet those siblings still developed WPW at a rate almost four times higher than the general population, with an adjusted hazard ratio of 3.79.² That means having a sibling with WPW meaningfully raises your own odds, but the absolute risk is still low.

An older but frequently cited series found that about 3.4 percent of WPW patients had one or more first-degree relatives who also had an accessory pathway.³ These numbers paint a consistent picture: a family link exists, but the overwhelming majority of WPW patients are the only ones in their family to have the condition.

The PRKAG2 Gene and True Familial WPW

The clearest genetic story involves mutations in a gene called PRKAG2. This gene encodes a subunit of an enzyme involved in how heart cells manage energy. Mutations in PRKAG2 cause a distinctive syndrome that includes not just WPW-type pre-excitation but also thickening of the heart muscle and progressive problems with the heart’s normal conduction system.⁴ It follows an autosomal dominant inheritance pattern, meaning a single copy of the mutated gene from either parent is enough to cause the syndrome.⁵

Here is the catch, though: PRKAG2 mutations explain the familial clusters that made researchers suspect a genetic cause in the first place, but they don’t appear to explain isolated WPW. When researchers have screened large groups of patients who have WPW without any accompanying heart-muscle disease, they generally haven’t found PRKAG2 mutations.³ So PRKAG2 seems to be the gene behind a specific, recognizable form of the disease, one that comes bundled with other cardiac problems, rather than the explanation for WPW in general.

The syndrome caused by PRKAG2 mutations deserves attention because it tends to be more aggressive than ordinary WPW. The heart-muscle thickening and progressive conduction disease mean that these patients need closer monitoring and sometimes different treatment decisions than someone whose only issue is an isolated accessory pathway.

Other Genetic Conditions That Produce a WPW-Like Pattern

PRKAG2 is not the only genetic disorder that can show up looking like WPW on an electrocardiogram. Danon disease, a rare condition caused by mutations in the LAMP2 gene on the X chromosome, frequently produces a WPW-type pre-excitation pattern. Danon disease affects both skeletal and cardiac muscle, and its typical cardiac picture involves severe thickening of the heart walls alongside the telltale short PR interval and delta wave of WPW.⁶ In Danon disease, the pre-excitation pattern may not even stem from a true accessory pathway in the classic sense but from abnormal electrical behavior within the thickened heart muscle itself.

There is also a case report of a child who carried a mutation in the MYH7 gene, which codes for a major structural protein in heart muscle, and who had both hypertrophic cardiomyopathy and WPW.⁷ That was described as the first known case of that particular pairing, so it’s not yet clear how commonly MYH7 mutations lead to WPW.

The practical lesson from these conditions is that when WPW shows up alongside heart-muscle thickening, especially in a young person, clinicians often look for an underlying genetic cause. The WPW pattern in these cases is essentially a symptom of a broader genetic disease rather than a standalone diagnosis.

How Accessory Pathways Form Before Birth

Understanding why most WPW cases appear sporadic requires a brief look at how the heart’s wiring develops. The heart’s conduction system is functionally formed by about the 16th week of pregnancy. During normal development, temporary muscular connections exist between the atria and ventricles. These are supposed to break down and disappear as the fibrous ring that separates the upper and lower chambers matures. An accessory pathway in WPW is essentially one of these temporary connections that never dissolved.⁸

The fact that these pathways are usually transient during fetal growth and sometimes persist by what seems to be chance helps explain why WPW so often shows up without a family history. The failure of a tiny strand of muscle tissue to regress at the right moment doesn’t necessarily require a genetic mutation. It could be influenced by subtle variations in timing, local signaling molecules, or other developmental factors that aren’t strongly heritable. This is why the condition can be present at birth, sometimes detected even in the fetus, and yet have no clear genetic fingerprint in most patients.

Why Most Cases Look Sporadic

The genetics of cardiac conduction are far more complicated than a single-gene, single-outcome model. A large genome-wide association study involving over 92,000 people of European descent identified 50 different regions of the genome associated with the PR interval, the segment of the heart’s electrical cycle most directly related to how signals travel from the atria to the ventricles.⁹ These regions each have small effects on conduction timing and involve a wide range of biological pathways.

For isolated WPW, no common genetic variant has emerged as a dominant risk factor. The condition may involve a combination of subtle developmental and genetic influences, none large enough to produce a recognizable inheritance pattern. This kind of multifactorial causation is actually the norm for many heart conditions. A trait can have a genetic contribution without being “genetic” in the way most people understand the word, that is, without being passed down predictably from parent to child. The Swedish sibling study captures this tension neatly: relatives do face higher risk than the general population, suggesting some shared genetic or environmental vulnerability, but the absolute number of affected families is tiny.

Identical twins provide an interesting test case. Reports exist of identical twins who both have WPW, which is suggestive of a genetic influence. But case reports of identical twins where only one twin has WPW also exist. If the condition were fully determined by genetics, you’d expect identical twins to always share it. The incomplete concordance points again to a role for developmental chance alongside whatever genetic predisposition exists.

When WPW Accompanies Congenital Heart Defects

WPW appears at unusually high rates in people born with certain structural heart abnormalities, particularly Ebstein anomaly, a malformation of the tricuspid valve on the right side of the heart. The association is so strong that risk-factor analyses of children with WPW consistently identify Ebstein malformation as a predictor of life-threatening cardiac events.¹⁰ In Ebstein anomaly, the abnormal anatomy of the valve and surrounding tissue appears to create a physical substrate for accessory pathways, sometimes multiple ones.

The link between Ebstein anomaly and WPW is not strictly a genetic inheritance story in the classical sense. Ebstein anomaly itself has complex and largely unclear origins. But the co-occurrence tells us that structural disruptions during heart development can directly produce the conditions for WPW. For families where a child has both Ebstein anomaly and WPW, genetic counseling may focus more on the structural heart defect than on WPW specifically.

What WPW Risks Look Like in Practice

Most people with WPW live normal lives, and many never experience symptoms. The concern is that in a small percentage of cases, the accessory pathway can conduct dangerously fast electrical signals, especially if atrial fibrillation develops. When the atria fibrillate, electrical impulses fire chaotically, and if those impulses travel down a fast-conducting accessory pathway to the ventricles, the result can be a life-threatening rhythm.

Several mechanisms appear to link WPW to atrial fibrillation. The accessory pathway itself may predispose the atrial tissue to electrical instability, and the rapid looping rhythms that WPW causes can sometimes degenerate into atrial fibrillation on their own.¹¹ The coexistence of a functional accessory pathway and sustained episodes of rapid re-entrant tachycardia has been identified as an important trigger for atrial fibrillation in WPW patients.¹²

In children with WPW, a multicenter study found that risk factors for life-threatening events included male sex, Ebstein malformation, rapid conduction through the accessory pathway, having multiple pathways, and the ability to induce atrial fibrillation during electrophysiology testing.¹⁰ A specific metric clinicians use is the shortest interval between pre-excited heartbeats during atrial fibrillation: when that interval falls below 250 milliseconds, the pathway is considered high risk.¹³ The genetic subtype matters here too: patients whose WPW is part of a PRKAG2 syndrome or another genetic cardiac condition may carry additional risks from the associated heart-muscle disease.

What This Means for Family Members

If you have WPW and wonder whether your children or siblings should be screened, the answer depends heavily on context. For isolated WPW with no heart-muscle thickening and no family history, the risk to relatives is elevated compared to the general population but still low in absolute terms. The Swedish data put the incidence among siblings at about 0.12 per 1,000 person-years, compared to 0.03 per 1,000 person-years in the general population.² That translates to a roughly one-in-eight-thousand annual chance for siblings, up from about one in thirty thousand. Not zero, but not high enough to justify invasive testing on its own.

A simple electrocardiogram is a reasonable screening tool for close relatives, especially if the person with WPW also has any sign of heart-muscle thickening. If the WPW is suspected to be part of a broader genetic syndrome, particularly involving PRKAG2 or Danon disease, then genetic testing of family members becomes much more relevant. Those syndromes have a clear inheritance pattern, and finding out whether relatives carry the same mutation can directly change their medical management.

Distinguishing True Accessory Pathways from Lookalikes

Not every abnormal-looking conduction finding on an ECG represents a true accessory pathway. Some patients, especially those with hypertrophic cardiomyopathy, may show pre-excitation patterns caused by different structures, such as fasciculoventricular fibers, which connect the normal conduction system directly to the ventricle without creating the same re-entrant circuit risk as a classic WPW pathway.¹⁴ Distinguishing between these requires invasive electrophysiology study, where catheters placed inside the heart can directly map the electrical connections.

This distinction matters for the genetics question because some of the genetic conditions that mimic WPW on a surface ECG may not actually involve a true accessory pathway. Danon disease, for instance, can produce a WPW-like ECG pattern through abnormal electrical conduction in thickened heart tissue rather than through a discrete muscular bridge. Getting the anatomy right influences both risk assessment and treatment planning. A patient with a true accessory pathway may be a candidate for catheter ablation, where the pathway is destroyed with targeted energy. A patient whose WPW pattern comes from diffuse muscle disease may not benefit from the same procedure.

The Ongoing Search for Genetic Answers

Researchers have been exploring the genetic basis of WPW for over two decades. The identification of PRKAG2 as the gene behind familial WPW was a landmark finding, and the syndrome’s discoverers were among the first to connect a specific gene to this condition.¹⁵ Since then, the hope has been that similar discoveries would explain the broader population of WPW patients. That hasn’t happened yet.

The large genome-wide association studies that have mapped dozens of loci involved in cardiac conduction haven’t produced a clean hit for isolated WPW.⁹ Part of the difficulty is that WPW is not primarily a disorder of conduction speed or timing; it’s a structural anomaly, a piece of tissue that shouldn’t be there. Genetic variants that subtly shift how fast electrical signals move through the heart might influence whether an accessory pathway causes symptoms, but they may not explain why the pathway exists in the first place. The developmental biology of the fibrous ring, the structure that normally separates the atria from the ventricles, remains an active area of research, and future work combining developmental genetics with clinical electrophysiology may eventually fill in the gaps.

For now, the honest summary is that WPW sits in a gray zone. Specific rare genetic syndromes can cause it directly, and having a relative with WPW does modestly raise your own risk. But the vast majority of cases arise without a clear genetic explanation, likely from a combination of subtle developmental variation and genetic background that researchers have not yet been able to untangle.